nutch_noindex
CANCEL
/nutch_noindex

Ann Yeh, MD

  • Ann Ming Yeh
  • “I treat each patient in a comprehensive, holistic way — looking at them as a whole person.”

I love pediatric gastroenterology, because it allows me to see children during various stages of their life. From babies with feeding problems to teenagers with irritable bowel syndrome, I feel fortunate to care for young people across a wide range of ages and conditions.

I practice integrative medicine, which means I take conventional therapies and complement them with alternative practices, such as acupuncture, which Im certified in. I use a combination of approaches to treat patients who may have not had success with conventional therapies alone.

Many of my patients are referred to me, because their doctors have tried everything, and nothing has worked. I use an integrative approach to treat each patient in a comprehensive, holistic way, looking at them as a whole person, not just as a condition.

Integrative medicine is a fascinating field. There's growing scientific evidence and support for acupuncture, good nutrition, physical activity, and meditation. We really need to look at the whole picture of why a patient might not be feeling well. I'm so fortunate to be able to practice this work, and to help patients achieve their best health.

Specialties

Gastroenterology

Work and Education

Professional Education

Albert Einstein College of Medicine, Bronx, NY, 2006

Residency

Stanford University School of Medicine, Stanford, CA, 2009

Fellowship

Stanford University School of Medicine, Palo Alto, CA, 2013

University of Arizona - Center for Integrative Medicine, Tucson,, AZ, 10/28/2014

Board Certifications

Acupuncture, American Board of Medical Acupuncture

Pediatric Gastroenterology, American Board of Pediatrics

Pediatrics, American Board of Pediatrics

All Publications

Mind-Body Interventions for Pediatric Inflammatory Bowel Disease. Children (Basel, Switzerland) Yeh, A. M., Wren, A., Golianu, B. 2017; 4 (4)

Abstract

Pediatric inflammatory bowel disease is an autoimmune disease that causes chronic inflammation of the gastrointestinal mucosa. There is emerging evidence that the brain-gut connection affects inflammatory bowel disease (IBD) patients more than previously thought. This is evidenced by comorbid mood disorders, irritable bowel symptoms concurrent with quiescent IBD, and the potential of psychosocial stressors to trigger IBD flares. Mind-body interventions such as psychotherapy, relaxation, mindfulness, biofeedback, yoga, and clinical hypnosis offer an adjunct to standard medical treatment for IBD. We will review the current evidence base for these mind- body interventions in the treatment of pediatric IBD, illustrate a case study, and offer suggestions for future research for this promising field.

View details for DOI 10.3390/children4040022

View details for PubMedID 28368365

Spanish and English Language Symposia to Enhance Activation in Pediatric Inflammatory Bowel Disease. Journal of pediatric gastroenterology and nutrition Martin, M., Garcia, M., Christofferson, M., Bensen, R., Yeh, A. M., Park, K. T. 2016; 63 (5): 508-511

Abstract

Patient activation is an important consideration for improved health outcomes in the management of chronic diseases. Limited English proficiency (LEP) among patients and primary care providers has been shown to be a predictor for worse health across disease states. We aimed to determine the baseline patient activation measure (PAM) among Spanish-speaking (SP) and English-speaking (ES) pediatric IBD patients and parents, and to describe the feasibility and efficacy of a novel peer-group education symposium designed to enhance patient activation as measured with the PAM.Two separate half-day educational symposia in either Spanish or English were presented and moderated by 2 native Spanish-speaking physicians. Content for each of the presentations were highly standardized and interactive, designed to address each of the activation domains (self-management, collaboration with a health care provider, maintenance of function and prevention of disease exacerbation, and appropriate access to high-quality care). Descriptive statistics were used to describe changes between pre- and post-symposium PAM trends.11 primarily SP and 21 ES families participated in their respective symposium. Paired pre- and post-PAM scores were available from 24 pediatric IBD patients (8 SP; 16 ES) and 41 parents (15 SP; 26 ES). The mean age for SP and ES patients was 11.6 and 12.0 years, and female gender in 80% and 62%, respectively. Paired pre- and post-PAM scores for all participants (n=65) were analyzed. PAM scores uniformly increased in all 4 groups after the symposia (SP-patients 59.1 to 70.3, P=0.05; SP-parents 69.8 to 75.2, P=0.2; ES-patients 59.9 to 64.0, P=0.08; ES-parents 61.9 to 69.1, P=0.002), although only the ES-parents group had sufficient sample size (n=26) to achieve statistical significance. The overall cohort had an aggregate increase from pre-PAM of 62.9 (SD 14.5) to post-PAM of 69.4 (SD 13.9) (<0.001).We describe a novel peer-group educational symposium presented in Spanish and English languages to increase patient and parent activation in pediatric IBD patients and their care-giving parents. The use of PAM to assess levels of activation appears to be feasible and effective in these groups.

View details for PubMedID 27031374

Bugs and Guts: Practical Applications of Probiotics for Gastrointestinal Disorders in Children NUTRITION IN CLINICAL PRACTICE Barnes, D., Yeh, A. M. 2015; 30 (6): 747-759

View details for DOI 10.1177/0884533615610081

View details for Web of Science ID 000364637500003

View details for PubMedID 26538058

Integrative Treatment of Reflux and Functional Dyspepsia in Children. Children (Basel, Switzerland) Yeh, A. M., Golianu, B. 2014; 1 (2): 119-133

Abstract

Gastroesophageal reflux disease (GERD) and functional dyspepsia (FD) are common problems in the pediatric population, with up to 7% of school-age children and up to 8% of adolescents suffering from epigastric pain, heartburn, and regurgitation. Reflux is defined as the passage of stomach contents into the esophagus, while GERD refers to reflux symptoms that are associated with symptoms or complications-such as pain, asthma, aspiration pneumonia, or chronic cough. FD, as defined by the Rome III classification, is a persistent upper abdominal pain or discomfort, not related to bowel movements, and without any organic cause, that is present for at least two months prior to diagnosis. Endoscopic examination is typically negative in FD, whereas patients with GERD may have evidence of esophagitis or gastritis either grossly or microscopically. Up to 70% of children with dyspepsia exhibit delayed gastric emptying. Treatment of GERD and FD requires an integrative approach that may include pharmacologic therapy, treating concurrent constipation, botanicals, mind body techniques, improving sleep hygiene, increasing physical activity, and traditional Chinese medicine and acupuncture.

View details for DOI 10.3390/children1020119

View details for PubMedID 27417471

View details for PubMedCentralID PMC4928719

Acupuncture for Pediatric Pain. Children (Basel, Switzerland) Golianu, B., Yeh, A. M., Brooks, M. 2014; 1 (2): 134-148

Abstract

Chronic pain is a growing problem in children, with prevalence as high as 30.8%. Acupuncture has been found to be useful in many chronic pain conditions, and may be of clinical value in a multidisciplinary treatment program. The basic principles of acupuncture are reviewed, as well as studies exploring basic mechanisms of acupuncture and clinical efficacy. Conditions commonly treated in the pediatric pain clinic, including headache, abdominal pain, fibromyalgia, juvenile arthritis, complex regional pain syndrome, cancer pain, as well as perioperative pain studies are reviewed and discussed. Areas in need of further research are identified, and procedural aspects of acupuncture practice and safety studies are reviewed. Acupuncture can be an effective adjuvant in the care of pediatric patients with painful conditions, both in a chronic and an acute setting. Further studies, including randomized controlled trials, as well as trials of comparative effectiveness are needed.

View details for DOI 10.3390/children1020134

View details for PubMedID 27417472

View details for PubMedCentralID PMC4928723

Infliximab for the treatment of granulomatous peritonitis. Digestive diseases and sciences Yeh, A. M., Kerner, J., Hillard, P., Bass, D. 2013; 58 (12): 3397-3399

View details for DOI 10.1007/s10620-013-2726-6

View details for PubMedID 23817923

Acute Liver Failure and Aplastic Anemia in an 11-Year-Old Girl DIGESTIVE DISEASES AND SCIENCES Yeh, A. M., Mojtahed, A., Bass, D. 2011; 56 (8): 2237-2240

View details for DOI 10.1007/s10620-011-1678-y

View details for Web of Science ID 000293296100006

View details for PubMedID 21442323